Detalles de la búsqueda
1.
Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants.
Tumour Biol
; 39(2): 1010428317694327, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28240049
2.
The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.
BMC Cancer
; 14: 594, 2014 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25128202
3.
Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
BMC Immunol
; 11: 19, 2010 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20385003
4.
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.
Oncologist
; 15(7): 699-731, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20584808
5.
Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.
BMC Cancer
; 10: 117, 2010 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20346145
6.
Biomarker recommendation for PD-1/PD-L1 immunotherapy development in pediatric cancer based on digital image analysis of PD-L1 and immune cells.
J Pathol Clin Res
; 6(2): 124-137, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922656
7.
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.
Mol Oncol
; 13(5): 1196-1213, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859681
8.
Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers.
J Mol Diagn
; 10(2): 154-9, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18258928
9.
Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
Mol Oncol
; 12(6): 830-854, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603584
10.
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.
Cancers (Basel)
; 10(4)2018 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29690507
11.
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation.
Oncoimmunology
; 7(7): e1440167, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29900042
12.
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients.
Clin Colorectal Cancer
; 17(2): e369-e379, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29605591
13.
A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
J Mol Diagn
; 19(1): 162-168, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27865784
14.
MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients.
J Cancer
; 8(12): 2154-2162, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819417
15.
Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines.
Cancer Biother Radiopharm
; 32(7): 229-238, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28910149
16.
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.
Oncotarget
; 8(43): 74058-74067, 2017 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29088768
17.
Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia.
J Cancer
; 8(8): 1441-1452, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28638459
18.
TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value.
Crit Rev Oncol Hematol
; 99: 63-73, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689115
19.
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer.
World J Clin Oncol
; 7(6): 425-432, 2016 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28008383
20.
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.
Cancer Lett
; 375(2): 313-322, 2016 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26975633